The mechanism of motion of strontium ranelate is not really quite very clear but is believed that strontium ranelate inhibits osteoclast function and osteoblast exercise by way of a calcium-sensing receptor (CaSR) by strontium resulting in greater BMD and diminished fracture risks [148]. Be a part of the dialogue about https://www.directivepublications.org/the-journal-of-molecular-biology/